Holen Sie sich die Stockscreener-App
5.30
8.15%
-0.47
Vorhandelsmarkt:
5.12
-0.18
-3.40%
Schlusskurs vom Vortag:
$5.77
Offen:
$5.37
24-Stunden-Volumen:
188.84K
Relative Volume:
0.28
Marktkapitalisierung:
$5.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.71M
KGV:
-0.4526
EPS:
-11.71
Netto-Cashflow:
$-18.24M
1W Leistung:
-39.43%
1M Leistung:
-44.76%
6M Leistung:
-63.45%
1J Leistung:
-95.07%
1-Tages-Spanne:
$5.18
$5.78
1-Wochen-Bereich:
$5.18
$9.8908
52-Wochen-Spanne:
$5.18
$117.50
Genprex Inc Stock (GNPX) Company Profile
Firmenname
Genprex Inc
Sektor
Branche
Telefon
512-537-7997
Adresse
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Vergleichen Sie GNPX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
5.30 | 5.80M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-26 | Eingeleitet | National Securities | Buy |
| 2019-04-29 | Eingeleitet | Noble Capital Markets | Outperform |
Genprex Inc Aktie (GNPX) Neueste Nachrichten
Analyzing drawdowns of Genprex Inc. with statistical toolsJuly 2025 Catalysts & Long-Term Capital Growth Strategies - newser.com
Is Genprex Inc. stock safe for conservative investors2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com
Why Genprex Inc. stock remains undervalued2025 Key Lessons & Weekly Breakout Stock Alerts - newser.com
Genprex Inc. stock retracement – recovery analysis2025 Top Gainers & Smart Allocation Stock Tips - newser.com
What technical models suggest about Genprex Inc.’s comebackJuly 2025 Review & High Conviction Investment Ideas - newser.com
How Genprex Inc. stock responds to policy changes2025 Big Picture & Low Risk Entry Point Tips - newser.com
Can Genprex Inc. (2DE0) stock stage a strong rebound this quarter2025 Macro Impact & Risk Adjusted Buy/Sell Alerts - newser.com
Why Genprex Inc. stock is popular among millennialsMarket Weekly Review & Long-Term Safe Investment Plans - newser.com
Can Genprex Inc. (2DE0) stock reach $200 price targetEarnings Miss & Short-Term High Return Strategies - newser.com
How to integrate Genprex Inc. into portfolio analysis toolsPortfolio Update Report & Verified Chart Pattern Signals - newser.com
What indicators show strength in Genprex Inc.2025 Market Overview & Daily Risk Controlled Trade Plans - newser.com
Can Genprex Inc. (2DE0) stock sustain margin levels2025 Analyst Calls & Growth Focused Entry Reports - newser.com
Why analysts recommend Genprex Inc. (2DE0) stock2025 Technical Patterns & Safe Capital Preservation Plans - newser.com
Will Genprex Inc. stock deliver consistent dividendsJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - newser.com
Tools to monitor Genprex Inc. recovery probability2025 Volatility Report & Safe Capital Preservation Plans - newser.com
Backtesting results for Genprex Inc. trading strategiesWeekly Stock Analysis & Short-Term Trading Alerts - newser.com
Will Genprex Inc. stock reach Wall Street targetsEarnings Overview Summary & AI Enhanced Trade Execution Alerts - newser.com
Is Genprex Inc. stock ready for a breakout2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com
Can technical indicators confirm Genprex Inc.’s reversalQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
How institutional ownership impacts Genprex Inc. stockJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
How Genprex Inc. (2DE0) stock reacts to Fed tightening2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
Why OUTFRONT Media Inc. stock attracts strong analyst attention - newser.com
Finanzdaten der Genprex Inc-Aktie (GNPX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):